Is OncoSTRAT&GO the right test right for you?

This test is about helping you and your clinician determine the best treatment plan for you based on the analysis of your tumour and blood. It looks for the presence of specific biomarkers and can identify how your cancer is likely to respond to classic chemotherapies as well as other targeted therapies and immunotherapies.

It is relevant if you have Stage IV in Breast HR+ /HR2+, Colon, Prostate, NSCLC (Non-Small Cell Lung Cancer) or CUP (Cancer of Unknown Primary). For other cancers, see our OncoDEEP test – Click here.

Ask your clinician how you can get this test, or download this leaflet to give to them.

For you

There are huge number of drugs and therapies to treat cancers, and the more your clinician knows about the exact composition and behaviour of your tumour, the better they will be able to specify the combination that will be most effective for you in terms of survival rates and quality of life.

New treatments – and those you may not need

OncoSTRAT&GO results cover all therapies with potential clinical benefit – possibly including those which have not been considered for you before.

It will also help determine which ones which are not likely to benefit you, so you avoid unnecessary treatments (and any associated side effects and cost).

You can discuss this with your clinician, or if you would like to talk to one of our experts about this test, call us on +44 (0) 1270 623 179

What do I need to do?

This test is an analysis of your tumour tissue and blood. You will have had a biopsy and blood tests before you received your cancer diagnosis, and we can use the samples taken at that time so you do not need an additional medical procedure to take this test.

Through your clinician:

This test is only available through your clinician, who will receive your test results directly.

Step 1: Buy the test

You will receive an email asking you to confirm that you have authorised Everything Genetic Ltd to be given a sample of your tumour tissue/blood.

Step 2:

We will contact your pathologist directly and organise the collection of your samples and delivery to the lab.

Step 3: Reporting

Your samples will be analysed and a report will be generated, usually within seven working days of their receipt in the laboratory.

Step 4: Results

We analyse the cancer genes by deep sequencing and looking at protein effectors and any validated biomarkers. Your clinician will receive a comprehensive report covering all of these elements together with details of specific therapies and clinical trials relevant to you.

We also offer OncoTRACE – a test which shows the effect treatments are having on your cancer. Click here to find out more.

Onco DNA Tests information for Clinicians

OncoDNA’s innovative approach is to combine next-generation sequencing (NGS) with immunohistochemistry (IHC). This gives a comprehensive view of a tumour profile, at both DNA and protein levels and opens more therapeutic options for your patient.

In 2016, liquid biopsy analyses were added to its solution portfolio, either in combination with solid biopsy analysis or as a stand-alone analysis for diagnostic or monitoring purposes.